Skip to main content

News

CalPERS presses ahead with $37 million STP plan

The California Public Employees Retirement System is moving forward with its $37 million four-year straight-through processing project, despite the delay of the T+1 deadline, and the economic conditions that have shrunk the fund manager’s assets under…

Mizuho to launch ¥1.27 trillion CuBic One synthetic CLO

Mizuho Corporate Bank, a unit of Japan's Mizuho Holdings, is launching a ¥1.27 trillion ($10.4 billion) three-year synthetic balance sheet collateralised loan obligation (CLO), via special purpose vehicle CuBic One Limited. Mizuho International and…

Lehman takes a proprietary route to STP integration

US investment bank Lehman Brothers will rely on proprietary technology rather than industry standards to achieve straight-through processing (STP), Patrick Maher, Lehman vice-president of operations technology told delegates at Waters Magazine’s 2002…

US corporate hedging declines, says AFP

A majority of US corporate respondents to a recent survey by the Maryland-based Association of Finance Professionals (AFP) reported that overall hedging activity has declined, with a third citing derivatives accounting rule FAS 133 as the reason for the…

Isda worried about OTC regulation threats

The International Swaps and Derivatives Association is still voicing concern about attempts by US Californian Democrat senator Dianne Feinstein to regulate the energy and commodity derivatives market.

Isda concerned about Basel II cross-border operation

The biggest concern arising from the Basel II capital Accord is how it will operate for banks across national borders, says Tanya Castell, London-based head of investment bank UBS Warburg’s risk policy group and the chair of the International Swaps and…

Icap retains Washington lobbyists

UK inter-dealer broker Icap has retained the services of a professional lobbying company in Washington to combat negative political sentiment and ensure the broker’s interests are fully represented on Capitol Hill.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here